131 related articles for article (PubMed ID: 38625747)
1. The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.
Lafront C; Germain L; Campolina-Silva GH; Weidmann C; Berthiaume L; Hovington H; Brisson H; Jobin C; Frégeau-Proulx L; Cotau R; Gonthier K; Lacouture A; Caron P; Ménard C; Atallah C; Riopel J; Latulippe É; Bergeron A; Toren P; Guillemette C; Pelletier M; Fradet Y; Belleannée C; Pouliot F; Lacombe L; Lévesque É; Audet-Walsh É
J Clin Invest; 2024 Apr; 134(11):. PubMed ID: 38625747
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation.
Lafront C; Germain L; Weidmann C; Audet-Walsh É
Sci Rep; 2020 Mar; 10(1):4024. PubMed ID: 32132580
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer.
Mishra S; Tai Q; Gu X; Schmitz J; Poullard A; Fajardo RJ; Mahalingam D; Chen X; Zhu X; Sun LZ
Oncotarget; 2015 Dec; 6(42):44388-402. PubMed ID: 26575018
[TBL] [Abstract][Full Text] [Related]
4. IL-1-conferred gene expression pattern in ERα
Nawas AF; Kanchwala M; Thomas-Jardin SE; Dahl H; Daescu K; Bautista M; Anunobi V; Wong A; Meade R; Mistry R; Ghatwai N; Bayerl F; Xing C; Delk NA
BMC Cancer; 2020 Jan; 20(1):46. PubMed ID: 31959131
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity.
Takizawa I; Lawrence MG; Balanathan P; Rebello R; Pearson HB; Garg E; Pedersen J; Pouliot N; Nadon R; Watt MJ; Taylor RA; Humbert P; Topisirovic I; Larsson O; Risbridger GP; Furic L
Oncotarget; 2015 Jan; 6(2):604-16. PubMed ID: 25436982
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.
Moore RL; Faller DV
J Endocrinol; 2013 Mar; 216(3):273-85. PubMed ID: 23169992
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.
Aakula A; Leivonen SK; Hintsanen P; Aittokallio T; Ceder Y; Børresen-Dale AL; Perälä M; Östling P; Kallioniemi O
Mol Oncol; 2015 Aug; 9(7):1287-300. PubMed ID: 25907805
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3.
Slavin S; Yeh CR; Da J; Yu S; Miyamoto H; Messing EM; Guancial E; Yeh S
Carcinogenesis; 2014 Jun; 35(6):1301-9. PubMed ID: 24374826
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Receptor Alpha (ERα)-Associated Fibroblasts Promote Cell Growth in Prostate Cancer.
Da J; Lu M; Wang Z
Cell Biochem Biophys; 2015 Dec; 73(3):793-8. PubMed ID: 27259327
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer.
Bonkhoff H; Fixemer T; Hunsicker I; Remberger K
Prostate; 2000 Sep; 45(1):36-41. PubMed ID: 10960840
[TBL] [Abstract][Full Text] [Related]
13. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
[TBL] [Abstract][Full Text] [Related]
14. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.
Yeh CR; Slavin S; Da J; Hsu I; Luo J; Xiao GQ; Ding J; Chou FJ; Yeh S
Mol Cancer; 2016 Jan; 15():7. PubMed ID: 26790618
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
17. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
Bonkhoff H
Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
Omoto Y; Iwase H
Cancer Sci; 2015 Apr; 106(4):337-43. PubMed ID: 25611678
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Setlur SR; Mertz KD; Hoshida Y; Demichelis F; Lupien M; Perner S; Sboner A; Pawitan Y; Andrén O; Johnson LA; Tang J; Adami HO; Calza S; Chinnaiyan AM; Rhodes D; Tomlins S; Fall K; Mucci LA; Kantoff PW; Stampfer MJ; Andersson SO; Varenhorst E; Johansson JE; Brown M; Golub TR; Rubin MA
J Natl Cancer Inst; 2008 Jun; 100(11):815-25. PubMed ID: 18505969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
